All Stories

  1. nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy

    Article • Lung Cancer Targets and Therapy, October 2017, Dove Medical Press

    Prof Michael Thomas, Dr Oscar Juan, Amy Ko

  2. Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer

    Article • ClinicoEconomics and Outcomes Research, December 2016, Dove Medical Press

    Dr Oscar Juan